Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ANAB - ANAPTYSBIO, INC


IEX Last Trade
14.345
0.150   1.046%

Share volume: 27,459
Last Updated: Mon 13 Jan 2025 08:30:08 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.44%

PREVIOUS CLOSE
CHG
CHG%

$14.20
0.15
1.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 2024-05-09 2023-08-07 2023-11-02 2024-11-05 2024-05-09 2024-08-05 2024-11-05
Total revenue 1.374 M 3.460 M 3.318 M 9.005 M 7.179 M 10.971 M 30.017 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 1.374 M 3.460 M 3.318 M 9.005 M 7.179 M 10.971 M 30.017 M
    151.82% -4.10% 171.40% -20.28% 52.82% 173.60%  
Operating expenses 45.775 M 43.603 M 41.050 M 51.140 M 49.380 M 51.292 M 52.774 M
Selling general and admin 10.818 M 10.680 M 10.172 M 10.276 M 12.338 M 9.295 M 10.562 M
Research and development 34.957 M 32.923 M 30.878 M 40.864 M 37.042 M 41.997 M 42.212 M
Total expenses 45.775 M 43.603 M 41.050 M 51.140 M 49.380 M 51.292 M 52.774 M
    -4.74% -5.86% 24.58% -3.44% 3.87% 2.89%  
Operating income -44.401 M -40.143 M -37.732 M -42.135 M -42.201 M -40.321 M -22.757 M
Ebit -44.405 M -40.140 M -37.731 M -42.137 M -42.203 M -40.321 M -22.762 M
Pretax income -44.255 M -39.845 M -37.308 M -42.215 M -43.936 M -46.651 M -32.851 M
    -9.96% -6.37% 13.15% 4.08% 6.18% -29.58%  
Income tax 0.000 0.000 0.000 0.000 0.000 9.000 K 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -44.255 M -39.845 M -37.308 M -42.211 M -43.936 M -46.660 M -32.851 M
    9.96% 6.37% -13.14% -4.09% -6.20% 29.59%